Number of Clinical Trials 2014
Explore the number of clinical trials conducted in various countries; critical for medical research and innovation.
Newer data is available: Number of Clinical Trials by country 2024 →
Where does your country rank? Pick it to see its position.
Related Health statistics
More ↓Interactive Map
Complete Data Rankings
- #1
United States
- #2
France
- #3
Germany
- #4
Canada
- #5
United Kingdom
- #6
South Korea
- #7
China
- #8
Denmark
- #9
Italy
- #10
Spain
Analysis: These countries represent the highest values in this dataset, showcasing significant scale and impact on global statistics.
- #122
Papua New Guinea
- #121
State of Palestine
- #120
North Macedonia
- #119
Montenegro
- #118
Mongolia
- #117
Mauritius
- #116
Luxembourg
- #115
Kyrgyzstan
- #114
Jamaica
- #113
Iraq
Context: These countries or territories have the lowest values, often due to geographic size, administrative status, or specific characteristics.
Insights by country
Singapore
In 2014, Singapore ranked #31 globally with a total of 50 clinical trials. This figure is notably higher than that of many Southeast Asian neighbors, reflecting Singapore's status as a regional hub for biomedical research. The country's robust healthcare infrastructure, government support for innovation, and strategic investments in research and development significantly contribute to its clinical trial activity.
Canada
In 2014, Canada ranked #4 globally with a total of 527 clinical trials. This figure highlights Canada's robust research infrastructure, significantly higher than the global average. Key drivers include a strong emphasis on healthcare innovation, a well-established regulatory framework, and partnerships between academic institutions and the pharmaceutical industry.
Jordan
In 2014, Jordan ranked #59 globally with a total of 8 clinical trials. This figure is notably lower than the global average, reflecting the challenges faced by the country in attracting significant research investments compared to leading nations. Key drivers of this statistic include Jordan's limited healthcare funding and a smaller population base, which can hinder the scale and scope of clinical research initiatives.
Czech Republic
In 2014, the Czech Republic ranked #34 globally with a total of 28 clinical trials. This figure is relatively modest compared to leading countries in clinical research, such as the United States, which hosts thousands of trials annually. The Czech Republic benefits from a well-educated healthcare workforce and a supportive regulatory environment, which facilitates clinical research while attracting international pharmaceutical companies to conduct trials within its borders.
Venezuela
In 2014, Venezuela ranked #122 globally with a total of 1 clinical trial. This figure is notably low compared to other countries, reflecting the country's position as the bottom-ranked nation in this category. Contributing factors include ongoing economic instability and a challenging political environment, which hinder investment in healthcare and research initiatives.
Egypt
In 2014, Egypt ranked #24 globally with a total of 76 clinical trials. This figure is notable when compared to other countries in the region, indicating a robust clinical research environment. The growth in clinical trials in Egypt can be attributed to its strategic geographic location, which facilitates international collaboration, as well as a growing population that presents a diverse pool for research studies.
Nepal
Nepal ranked #80 out of 122 countries for the Number of Clinical Trials in 2014, with a total of 3 trials conducted. This figure is significantly lower than many neighboring countries, which often have more robust clinical research infrastructures. Contributing factors include limited funding for healthcare initiatives, a smaller population base for trial recruitment, and regulatory challenges that hinder the growth of clinical research in the country.
State of Palestine
In 2014, the State of Palestine ranked #109 globally with a total of 1 clinical trial. This is significantly lower than many neighboring countries, reflecting limited resources and infrastructure for clinical research. The primary drivers behind this statistic include ongoing political instability and restrictions on movement, which hinder collaboration with international research entities and access to necessary funding.
Ukraine
In 2014, Ukraine ranked #65 globally with a total of 5 clinical trials. This figure is notably lower than many of its Eastern European neighbors, reflecting challenges in the region's healthcare infrastructure and regulatory environment. Factors such as ongoing political instability and limited investment in medical research have hindered the growth of clinical trials in Ukraine, impacting its ability to attract international pharmaceutical companies.
Gambia
In 2014, Gambia ranked #108 globally with a total of 1 clinical trial. This figure is notably low compared to many countries in the region, which often have multiple trials underway to address local health challenges. The limited number of clinical trials in Gambia can be attributed to factors such as a small population, underfunded healthcare infrastructure, and a lack of investment in research and development initiatives.
Analysis & Context
In 2014, the United States led the world in the Number of Clinical Trials with a total of 5193, while globally, the number ranged from a minimum of 1 to a maximum of 5193. The median number of clinical trials conducted worldwide was 7, providing a clear indication of the disparity in medical research activities across different countries.
Concentration of Clinical Trials in Developed Nations
The concentration of clinical trials in 2014 was heavily skewed towards developed nations, with the United States far outpacing other countries by a substantial margin. Following the U.S., France and Germany had 630 and 558 trials respectively. This trend can be attributed to several factors, including robust healthcare infrastructure, significant investment in biomedical research, and the presence of major pharmaceutical companies. Countries like Canada and the United Kingdom also featured prominently, with 527 and 477 trials, underscoring their capacity for medical innovation and research.
Limited Activity in Developing Regions
In stark contrast, several developing countries reported only 1 clinical trial each, including Bahrain, Congo, and Benin. The limited activity in these regions can often be linked to constrained economic resources, fewer research facilities, and a lack of regulatory frameworks conducive to supporting extensive clinical research. Moreover, geopolitical instability in some areas further hinders the establishment and execution of clinical trials.
Year-over-Year Changes and Emerging Trends
The data from 2014 also highlights significant year-over-year changes in clinical trial numbers. The United States saw an increase of 300 trials, a growth of 6.1%, reflecting ongoing advancements and investments in medical research. Similarly, the United Kingdom and China experienced notable increases of 94 and 70 trials respectively, indicating an expanding focus on healthcare innovation. On the other hand, some countries experienced declines; for instance, Taiwan saw a reduction of 39 trials, a decrease of 25.3%, potentially due to shifts in research priorities or economic constraints.
Implications for Global Health Research
The distribution of clinical trials in 2014 underscores the critical role of economic and infrastructural capabilities in facilitating medical research. Developed countries, with their established research ecosystems, continue to lead in clinical trials, driving innovation and new treatments. However, the limited participation of developing nations highlights the need for increased international collaboration and support to bridge the gap in global health research. By fostering partnerships and investing in capacity building, the global community can enhance the diversity and applicability of clinical research, ultimately benefiting a broader swath of the world's population.
Frequently Asked Questions About Number of Clinical Trials in 2014
Which country had the highest number of clinical trials in 2014?
The United States had the highest number of clinical trials in 2014, with a total of 5,193.
What was the average number of clinical trials conducted by countries in 2014?
The average number of clinical trials conducted by countries in 2014 was 98.22.
Which country had the lowest number of clinical trials in 2014?
Bahrain had the lowest number of clinical trials in 2014, with just 1 trial.
What was the median number of clinical trials conducted by countries in 2014?
The median number of clinical trials conducted by countries in 2014 was 6.5.
How many countries conducted only one clinical trial in 2014?
There were 10 countries that conducted only one clinical trial in 2014.
Which countries were in the top 10 for the number of clinical trials in 2014?
The top 10 countries for the number of clinical trials in 2014 were the United States, France, Germany, Canada, United Kingdom, South Korea, China, Denmark, Italy, and Spain.
Data Source
Number of clinical trials | ClinicalTrials.gov via Our World in Data
Data produced by ClinicalTrials.gov, compiled and published by Our World in Data as "Number of clinical trials".
Visit Data SourceCite this page
Geo Factbook. (n.d.). Number of Clinical Trials by Country, 2014. Retrieved November 16, 2026, from https://geofactbook.com/fact/number-of-clinical-trials/2014
The figures on this page come from Number of clinical trials | ClinicalTrials.gov via Our World in Data. For academic work, cite the original source as well.
›Embed this ranking on your site
Free to embed with attribution. Shows the top 10 countries and links back to the full ranking.